Anti-inflammatory therapy for ASCVD: what does the future hold?

Back

Open Access

Anti-inflammatory therapy for ASCVD: what does the future hold?

Session: Inflammation in atherosclerotic cardiovascular disease (ASCVD): the spark before the fire?

Topic: Inflammation and Immunity

Speaker: Professor L. Tokgozoglu (Ankara, TR) Professor P. Libby (Boston, US) Doctor P. Ridker (Boston, US)

About the speakers

Professor Lale Tokgozoglu

Hacettepe University, Ankara (Türkiye)

54 presentations

15 followers

Professor Peter Libby

Brigham and Women's Hospital, Boston (United States of America)

41 presentations

7 followers

Doctor Paul M Ridker

Brigham and Women's Hospital, Boston (United States of America)

42 presentations

9 followers

5 more presentations in this session

Welcome video.

Access

Video

Residual inflammatory risk: concept or clinical practice?

Speaker: Professor P. Libby (Boston, US) Doctor P. Ridker (Boston, US) Professor L. Tokgozoglu (Ankara, TR)

Access

Video

ASCVD and inflammation: what is the status quo?

Speaker: Doctor P. Ridker (Boston, US) Professor P. Libby (Boston, US) Professor L. Tokgozoglu (Ankara, TR)

Access

Video

Q&A.

Access

Summary and future directions.

Speaker: Professor P. Libby (Boston, US)

Access

Video

Access the full session

Inflammation in atherosclerotic cardiovascular disease (ASCVD): the spark before the fire?

Speakers: Professor L. Tokgozoglu, Professor P. Libby, Doctor P. Ridker, Professor P. Libby, Doctor P. Ridker...

Access

Video

About the event

ESC Congress 2022

26 August - 29 August 2022

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources